• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

散发性及1型神经纤维瘤病相关恶性外周神经鞘膜瘤中p15INK4b、p14ARF和p16INK4a的失活

p15INK4b, p14ARF, and p16INK4a inactivation in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors.

作者信息

Perrone Federica, Tabano Silvia, Colombo Federica, Dagrada Gianpaolo, Birindelli Sarah, Gronchi Alessandro, Colecchia Maurizio, Pierotti Marco A, Pilotti Silvana

机构信息

Unit of Experimental Molecular Pathology, Department of Pathology, Istituto Nazionale per lo Studio e la Cura dei Tumori di Milano, Via G. Venezian 1, 20133 Milan, Italy.

出版信息

Clin Cancer Res. 2003 Sep 15;9(11):4132-8.

PMID:14519636
Abstract

PURPOSE

Malignant peripheral nerve sheath tumor (MPNST) can arise sporadically or in association with neurofibromatosis type 1. Deletions at the 9p21 locus have been reported in these tumors. To additionally characterize the status of this chromosomal region, in this study we performed a comprehensive, mostly PCR-based molecular analysis of the three tumor suppressor genes p15(INK4b), p14(ARF) and p16(INK4a) located at the 9p21 locus in 26 cryopreserved MPNSTs.

EXPERIMENTAL DESIGN

Fourteen neurofibromatosis type 1-related and 12 sporadic cases were investigated for homozygous deletion coupled with fluorescent in situ hybridization, promoter methylation, and mutational analysis, as well as m-RNA expression.

RESULTS

The results showed that an inactivation of one or more genes occurred in 77% of MPNSTs and was mainly achieved through homozygous deletion (46%), which, in turn, encompassed all of the three tandemly linked genes in 83% of the deleted cases. Promoter methylation was at a less extent involved in gene silencing (18%), and no mutations were found. Loss of function at DNA level strongly correlated with loss of mRNA expression accounting for 80% of the cases. Because of the close relationship between p14(ARF) and TP53 and between p15(INK4b)/p16(INK4a) and Rb, these results support a model of a coinactivation of TP53 and Rb pathways in 75% of MPNSTs, with functional consequences on cell growth control and apoptosis.

CONCLUSIONS

The inactivation of the 9p21 locus is a frequent and peculiar hallmark of MPNST genetic profile leading also to an impaired apoptosis that could be taken into account in treatment planning of these tumors.

摘要

目的

恶性外周神经鞘瘤(MPNST)可散发性发生或与1型神经纤维瘤病相关。这些肿瘤中已报道9p21位点存在缺失。为进一步明确该染色体区域的状态,在本研究中,我们对26例冷冻保存的MPNST中位于9p21位点的三个肿瘤抑制基因p15(INK4b)、p14(ARF)和p16(INK4a)进行了全面的、主要基于PCR的分子分析。

实验设计

对14例与1型神经纤维瘤病相关的病例和12例散发性病例进行了纯合缺失研究,并结合荧光原位杂交、启动子甲基化、突变分析以及mRNA表达研究。

结果

结果显示,77%的MPNST中一个或多个基因发生失活,主要通过纯合缺失实现(46%),而在83%的缺失病例中,纯合缺失又累及所有三个串联的基因。启动子甲基化在基因沉默中参与程度较低(18%),未发现突变。DNA水平的功能丧失与mRNA表达缺失高度相关,占病例的80%。由于p14(ARF)与TP53以及p15(INK4b)/p16(INK4a)与Rb之间关系密切,这些结果支持了75%的MPNST中TP53和Rb通路共同失活的模型,对细胞生长控制和凋亡产生功能影响。

结论

9p21位点失活是MPNST基因谱中常见且独特的特征,也导致凋亡受损,这在这些肿瘤的治疗规划中应予以考虑。

相似文献

1
p15INK4b, p14ARF, and p16INK4a inactivation in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors.散发性及1型神经纤维瘤病相关恶性外周神经鞘膜瘤中p15INK4b、p14ARF和p16INK4a的失活
Clin Cancer Res. 2003 Sep 15;9(11):4132-8.
2
Prognostic significance of p14ARF, p15INK4b, and p16INK4a inactivation in malignant peripheral nerve sheath tumors.p14ARF、p15INK4b 和 p16INK4a 失活在恶性外周神经鞘瘤中的预后意义。
Clin Cancer Res. 2011 Jun 1;17(11):3771-82. doi: 10.1158/1078-0432.CCR-10-2393. Epub 2011 Jan 24.
3
9p21 locus analysis in high-risk gastrointestinal stromal tumors characterized for c-kit and platelet-derived growth factor receptor alpha gene alterations.针对c-kit和血小板衍生生长因子受体α基因改变的高危胃肠道间质瘤的9p21位点分析。
Cancer. 2005 Jul 1;104(1):159-69. doi: 10.1002/cncr.21113.
4
Aberrant methylation of p14(ARF), p15(INK4b) and p16(INK4a) genes and location of the primary site in pulmonary squamous cell carcinoma.p14(ARF)、p15(INK4b)和p16(INK4a)基因的异常甲基化与肺鳞状细胞癌原发部位的关系
Pathol Int. 2004 Aug;54(8):549-55. doi: 10.1111/j.1440-1827.2004.01663.x.
5
Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma.原发性葡萄膜黑色素瘤中TGFβ、Wnt、pRb和p53信号通路相关特定基因的突变分析
Invest Ophthalmol Vis Sci. 2002 Sep;43(9):2845-51.
6
Preferentially different mechanisms of inactivation of 9p21 gene cluster in liver fluke-related cholangiocarcinoma.肝吸虫相关胆管癌中9p21基因簇优先不同的失活机制
Hum Pathol. 2009 Jun;40(6):817-26. doi: 10.1016/j.humpath.2008.11.002. Epub 2009 Feb 5.
7
Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc.在体内因c-Myc失调而转化的小鼠骨髓细胞中,p19(Arf)持续失活,但p15(Ink4b)未失活。
Oncogene. 2003 Mar 20;22(11):1600-10. doi: 10.1038/sj.onc.1206268.
8
Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.光化性角化病中肿瘤抑制基因p14(ARF)、p15(INK4b)、p16(INK4a)和p53的基因组不稳定性、突变及表达分析
Cancer Lett. 2008 Jun 8;264(1):145-61. doi: 10.1016/j.canlet.2008.01.042. Epub 2008 Mar 10.
9
INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.肝细胞癌中的INK4a-ARF改变和p53突变
Oncogene. 2001 Oct 25;20(48):7104-9. doi: 10.1038/sj.onc.1204902.
10
Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.对头颈部鳞状细胞癌中CDKN2B(p15INK4b)、CDKN2A(p14ARF、p16INK4a)和MTAP基因的基因结构精细定位缺失。
Arch Otolaryngol Head Neck Surg. 2006 Apr;132(4):409-15. doi: 10.1001/archotol.132.4.409.

引用本文的文献

1
Consensus recommendations for an integrated diagnostic approach to peripheral nerve sheath tumors arising in the setting of Neurofibromatosis Type 1.1型神经纤维瘤病相关外周神经鞘瘤综合诊断方法的共识性建议
Neuro Oncol. 2025 Mar 7;27(3):616-624. doi: 10.1093/neuonc/noae235.
2
Breast Cancer and p16: Role in Proliferation, Malignant Transformation and Progression.乳腺癌与p16:在增殖、恶性转化及进展中的作用
Healthcare (Basel). 2021 Sep 21;9(9):1240. doi: 10.3390/healthcare9091240.
3
Efficacy of MEK inhibition in a recurrent malignant peripheral nerve sheath tumor.
MEK抑制在复发性恶性外周神经鞘瘤中的疗效
NPJ Precis Oncol. 2021 Feb 12;5(1):9. doi: 10.1038/s41698-021-00145-8.
4
Molecular targets for NF1-associated malignant peripheral nerve sheath tumor.神经纤维瘤病1型相关恶性外周神经鞘膜瘤的分子靶点
Rep Pract Oncol Radiother. 2020 Jul-Aug;25(4):556-561. doi: 10.1016/j.rpor.2020.04.010. Epub 2020 Apr 27.
5
CDKs in Sarcoma: Mediators of Disease and Emerging Therapeutic Targets.肉瘤中的 CDK :疾病的介质和新兴的治疗靶点。
Int J Mol Sci. 2020 Apr 24;21(8):3018. doi: 10.3390/ijms21083018.
6
Aberrant expression of p16 in human cancers - a new biomarker?p16在人类癌症中的异常表达——一种新的生物标志物?
Cancer Rep Rev. 2018 Mar;2(2). doi: 10.15761/CRR.1000145. Epub 2018 Jan 15.
7
NF1 Hematopoietic Cells Accelerate Malignant Peripheral Nerve Sheath Tumor Development without Altering Chemotherapy Response.NF1造血细胞加速恶性外周神经鞘瘤发展,且不改变化疗反应。
Cancer Res. 2017 Aug 15;77(16):4486-4497. doi: 10.1158/0008-5472.CAN-16-2643. Epub 2017 Jun 23.
8
Telomere erosion in NF1 tumorigenesis.神经纤维瘤病1型肿瘤发生过程中的端粒侵蚀
Oncotarget. 2017 Jun 20;8(25):40132-40139. doi: 10.18632/oncotarget.16981.
9
Epigenetic mechanisms drive the progression of neurofibromas to malignant peripheral nerve sheath tumors.表观遗传机制驱动神经纤维瘤向恶性外周神经鞘瘤进展。
Surg Neurol Int. 2016 Nov 14;7(Suppl 33):S797-S800. doi: 10.4103/2152-7806.194058. eCollection 2016.
10
Whole Exome Sequencing Reveals the Order of Genetic Changes during Malignant Transformation and Metastasis in a Single Patient with NF1-plexiform Neurofibroma.全外显子测序揭示了一名患有NF1丛状神经纤维瘤患者在恶性转化和转移过程中的基因变化顺序。
Clin Cancer Res. 2015 Sep 15;21(18):4201-11. doi: 10.1158/1078-0432.CCR-14-3049. Epub 2015 Apr 29.